{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:14:17Z","timestamp":1783988057869,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005716","name":"Babol University of Medical Sciences","doi-asserted-by":"publisher","award":["9911034"],"award-info":[{"award-number":["9911034"]}],"id":[{"id":"10.13039\/501100005716","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.msard.2022.103518","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T12:21:12Z","timestamp":1641817272000},"page":"103518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Intranasal administration of fingolimod (FTY720) attenuates demyelination area in lysolecithin-induced demyelination model of rat optic chiasm"],"prefix":"10.1016","volume":"59","author":[{"given":"Maryam","family":"Ghasemi-Kasman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Nosratiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Hashemian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyed-Raheleh","family":"Ahmadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Parsian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Rostami-Mansoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2022.103518_bib0001","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2018.05.011","article-title":"Nose-to-brain drug delivery: an update on clinical challenges and progress towards approval of anti-Alzheimer drugs","volume":"281","author":"Agrawal","year":"2018","journal-title":"J. Control. Release."},{"key":"10.1016\/j.msard.2022.103518_bib0002","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/B978-0-12-407239-8.00013-6","article-title":"Quantitative 3D cell-based assay performed with cellular spheroids and fluorescence microscopy","volume":"113","author":"Ansari","year":"2013","journal-title":"Methods. Cell. Biol."},{"key":"10.1016\/j.msard.2022.103518_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-017-0924-4","article-title":"Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis","volume":"14","author":"Bail","year":"2017","journal-title":"J. Neuroinflam."},{"key":"10.1016\/j.msard.2022.103518_bib0004","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1523\/JNEUROSCI.2346-19.2020","article-title":"Fingolimod rescues demyelination in a mouse model of Krabbe's disease","volume":"40","author":"B\u00e9chet","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.msard.2022.103518_bib0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000321044","article-title":"Nasal drug delivery in humans","volume":"40","author":"Bitter","year":"2011","journal-title":"Top. Applicat. Mucos."},{"key":"10.1016\/j.msard.2022.103518_bib0006","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nn0602-849","article-title":"Sniffing neuropeptides: a transnasal approach to the human brain","volume":"5","author":"Born","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.msard.2022.103518_bib0007","first-page":"213","article-title":"A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya)","volume":"12","author":"Chun","year":"2013","journal-title":"Discov. Med."},{"key":"10.1016\/j.msard.2022.103518_bib0008","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3390\/pharmaceutics12020093","article-title":"Targeting small molecule delivery to the brain and spinal cord via intranasal administration of rabies virus glycoprotein (RVG29)-modified PLGA nanoparticles","volume":"12","author":"Chung","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.msard.2022.103518_bib0009","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ana.22426","article-title":"Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis","volume":"6","author":"Cohen","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2022.103518_bib0010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.lfs.2017.12.025","article-title":"Mechanism of intranasal drug delivery directly to the brain","volume":"195","author":"Crowe","year":"2018","journal-title":"Life. Sci."},{"key":"10.1016\/j.msard.2022.103518_bib0011","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/j.pain.0000000000001106","article-title":"Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn","volume":"159","author":"Doolen","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.msard.2022.103518_bib0012","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jneuroim.2013.02.013","article-title":"Nasal administration of drugs as a new non-invasive strategy for efficient treatment of multiple sclerosis","volume":"258","author":"Duchi","year":"2013","journal-title":"J. Neuroimmun."},{"key":"10.1016\/j.msard.2022.103518_bib0013","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0378-5173(03)00039-5","article-title":"Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats","volume":"255","author":"Dufes","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msard.2022.103518_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-017-0882-x","article-title":"Sphingosine 1-phosphate receptor 3 and RhoA signaling mediate inflammatory gene expression in astrocytes","volume":"14","author":"Dusaban","year":"2017","journal-title":"J. Neuroinflam."},{"key":"10.1016\/j.msard.2022.103518_bib0015","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/jpet.107.127183","article-title":"Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis","volume":"323","author":"Foster","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.msard.2022.103518_bib0016","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1177\/1352458518763095","article-title":"Overexpression of sphingosine-1-phosphate receptors on reactive astrocytes drives neuropathology of multiple sclerosis rebound after fingolimod discontinuation","volume":"24","author":"Giordana","year":"2018","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2022.103518_bib0017","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejps.2016.09.016","article-title":"Fingolimod enhances myelin repair of hippocampus in pentylenetetrazol-induced kindling model","volume":"96","author":"Gol","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.msard.2022.103518_bib0018","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.brainresbull.2019.08.014","article-title":"Fingolimod (FTY720) improves the functional recovery and myelin preservation of the optic pathway in focal demyelination model of rat optic chiasm","volume":"153","author":"Hashemian","year":"2019","journal-title":"Brain. Res. Bull."},{"key":"10.1016\/j.msard.2022.103518_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-015-0393-6","article-title":"Fingolimod induces neuroprotective factors in human astrocytes","volume":"12","author":"Hoffmann","year":"2015","journal-title":"J. Neuroinflam."},{"key":"10.1016\/j.msard.2022.103518_bib0020","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jconrel.2017.09.001","article-title":"Progress in brain targeting drug delivery system by nasal route","volume":"268","author":"Khan","year":"2017","journal-title":"J. Control. Release."},{"key":"10.1016\/j.msard.2022.103518_bib0021","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11060-017-2388-x","article-title":"Plasma and cerebrospinal fluid pharmacokinetics of select chemotherapeutic agents following intranasal delivery in a non-human primate model","volume":"132","author":"League-Pascual","year":"2017","journal-title":"J. Neuro-oncol."},{"key":"10.1016\/j.msard.2022.103518_bib0022","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12031-018-1092-4","article-title":"An apparent correlation between central nervous system and kidney's erythropoietin and TNF alpha expression at peak experimental autoimmune encephalomyelitis disease","volume":"65","author":"Mansoor","year":"2018","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.msard.2022.103518_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116830","article-title":"The potential use of mesenchymal stem cells for the treatment of multiple sclerosis","volume":"235","author":"Mansoor","year":"2019","journal-title":"Life. Sci."},{"key":"10.1016\/j.msard.2022.103518_bib0024","article-title":"Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: an opportunity to develop new CNS drugs","volume":"209","author":"Mignani","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.msard.2022.103518_bib0025","doi-asserted-by":"crossref","DOI":"10.2353\/ajpath.2010.091234","article-title":"Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices","volume":"176","author":"Miron","year":"2010","journal-title":"Am. J. pathol."},{"key":"10.1016\/j.msard.2022.103518_bib0026","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1471-4159.2007.04629.x","article-title":"Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors","volume":"102","author":"Mullershausen","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.msard.2022.103518_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2018.03.018","article-title":"Curcumin-loaded nanoparticles ameliorate glial activation and improve myelin repair in lysolethitin focal demyelination model of rat corpus callosum","volume":"674","author":"Naeimi","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.msard.2022.103518_bib0028","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2012.12.005","article-title":"Fingolimod phosphate promotes the neuroprotective effects of microglia","volume":"256","author":"Noda","year":"2013","journal-title":"J. Neuroimmun."},{"key":"10.1016\/j.msard.2022.103518_bib0029","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.neuropharm.2006.11.010","article-title":"Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors","volume":"52","author":"Osinde","year":"2007","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.msard.2022.103518_bib0030","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/309342","article-title":"Clinical pharmacology of midazolam in neonates and children: effect of disease\u2014a review","author":"Pacifici","year":"2014","journal-title":"Int. j. ped."},{"key":"10.1016\/j.msard.2022.103518_bib0031","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/14656566.2018.1434143","article-title":"Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables","volume":"19","author":"Pitteri","year":"2018","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.msard.2022.103518_bib0032","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/brain\/aww298","article-title":"Myelin phagocytosis by astrocytes after myelin damage promotes lesion pathology","volume":"140","author":"Ponath","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.msard.2022.103518_bib0033","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/jnen\/nlz128","article-title":"Intranasal methylprednisolone effectively reduces neuroinflammation in mice with experimental autoimmune encephalitis","volume":"79","author":"Rassy","year":"2020","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.msard.2022.103518_bib0034","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005835","article-title":"Sphingosine-1-phosphate receptor modulator, FTY720, improves diastolic dysfunction and partially reverses atrial remodeling in a Tm-E180G mouse model linked to hypertrophic cardiomyopathy","volume":"12","author":"Ryba","year":"2019","journal-title":"Circ. Heart. Fail."},{"key":"10.1016\/j.msard.2022.103518_bib0035","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/jcb.20127","article-title":"Structural and functional characteristics of S1P receptors","volume":"92","author":"Sanchez","year":"2004","journal-title":"J. Cel. Biochem."},{"key":"10.1016\/j.msard.2022.103518_bib0036","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/pr.107.07113","article-title":"Inside-out\u201d signaling of sphingosine-1-phosphate: therapeutic targets","volume":"60","author":"Takabe","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.msard.2022.103518_bib0037","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/glia.21021","article-title":"Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions","volume":"58","author":"Van Doorn","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.msard.2022.103518_bib0038","first-page":"87","article-title":"Profiles of methotrexate in blood and CSF following intranasal and intravenous administration to rats","volume":"225","author":"Wang","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msard.2022.103518_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-7-30","article-title":"Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1\u03b2, TNF-\u03b1 and IL-6 in an in-vitro model of brain inflammation","volume":"7","author":"Wilms","year":"2010","journal-title":"J. Neuroinflam."},{"key":"10.1016\/j.msard.2022.103518_bib0040","first-page":"329","article-title":"Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes","volume":"20","author":"Yang","year":"2013","journal-title":"J. Alzheimer's. Dis."},{"key":"10.1016\/j.msard.2022.103518_bib0041","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ymthe.2016.12.008","article-title":"Effect of fingolimod on neural stem cells: a novel mechanism and broadened application for neural repair","volume":"25","author":"Zhang","year":"2017","journal-title":"Mol. Ther."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822000335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822000335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:57:46Z","timestamp":1761901066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034822000335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":41,"alternative-id":["S2211034822000335"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.103518","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal administration of fingolimod (FTY720) attenuates demyelination area in lysolecithin-induced demyelination model of rat optic chiasm","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.103518","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103518"}}